ABOS
Acumen Pharmaceuticals, Inc. · Healthcare
Director Jeffrey L. Ives sold $272K of Acumen Pharmaceuticals, Inc.
Sold$272,334
$6.49Price
41,949Shares
−100%Stake
What ABOS did after the filing
- The stock from Fri, Aug 18 close, $6.29
- −33.7%
- S&P 500, same days
- −1.8%
Measured over 30 trading days, to the Oct 2 close.
Traded Thu, Aug 17. Filed Fri, Aug 18, 2:31 PM ET, during the session. Returns use the Aug 18 close and the Oct 2 close. Not investment advice.